Regulation of the Immune System in Response to the Treatment With Tocilizumab in Rheumatoid Arthritis Patients

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2010
The purpose of this study is to know the level of expression and activation state of different transcription factors of the STAT family (STAT1, STAT3, STAT5A, STAT5B, STAT6) in the hematopoietic cells from tocilizumab treated patients.
Epistemonikos ID: e7fd1e46f59284c2215143b76fbf3c182b464fb1
First added on: May 11, 2024